title: Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.
abstract: The purpose of this study was to identify calcium channel and calmodulin antagonists effective in increasing the cytotoxic effects of several chemotherapeutic drugs against UV-2237 murine fibrosarcoma MDR cells. Among 8 compounds tested at nontoxic concentrations, flupentixol, a piperazine-substituted thioxanthene, was the most potent in enhancing the cytotoxicity of anticancer drugs commonly associated with the multidrug resistant (MDR) phenotype, such as Adriamycin, actinomycin D, vinblastine, and vincristine, but not 5-fluorouracil, a drug usually unaffected by MDR. The chemosensitizing effects of flupentixol were produced by increasing intracellular drug accumulation via a mechanism unrelated to the binding of the plasma membrane P-glycoprotein.
authors.affiliation: Department of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: D
authors.initials: D
authors.lastname: Fan
authors.forename: G
authors.initials: G
authors.lastname: Poste
authors.forename: C
authors.initials: C
authors.lastname: Seid
authors.forename: L E
authors.initials: LE
authors.lastname: Earnest
authors.forename: T
authors.initials: T
authors.lastname: Bull
authors.forename: R K
authors.initials: RK
authors.lastname: Clyne
authors.forename: I J
authors.initials: IJ
authors.lastname: Fidler
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002147:Calmodulin / Q000037:antagonists & inhibitors; D004317:Doxorubicin / Q000494:pharmacology; D004347:Drug Interactions; D018432:Drug Resistance, Multiple; D005354:Fibrosarcoma; D005475:Flupenthixol / Q000494:pharmacology*; D051379:Mice; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D002121:Calcium Channel Blockers; D002147:Calmodulin; D004317:Doxorubicin; D005475:Flupenthixol